Atacand HCT (Candesartan Cilexetil / Hydrochlorothiazide) - Summary

ATACAND HCT SUMMARY

ATACAND HCT® 16-12.5
(candesartan cilexetil−hydrochlorothiazide)
TABLETS
ATACAND HCT® 32-12.5
(candesartan cilexetil−hydrochlorothiazide)
TABLETS

ATACAND HCT (candesartan cilexetil-hydrochlorothiazide) combines an angiotensin II receptor (type AT₁) antagonist and a diuretic, hydrochlorothiazide.

ATACAND HCT is indicated for the treatment of hypertension. This fixed dose combination is not indicated for initial therapy.

When used in pregnancy during the second and third trimesters, drugs that act directly on the renin-angiotensin system can cause injury and even death to the developing fetus. When pregnancy is detected, ATACAND HCT should be discontinued as soon as possible. See WARNINGS, Fetal/Neonatal Morbidity and Mortality.

ATACAND HCT NEWS HIGHLIGHTS

Media Articles Related to Atacand HCT (Candesartan Cilexetil / Hydrochlorothiazide)

Pseudotumor Cerebri (Idiopathic Intracranial Hypertension)
Source: MedicineNet Brain Tumor Specialty [2008.09.30]

Study Finds Antioxidant Deficiency Linked To Pulmonary Hypertension
Source: Hypertension News From Medical News Today [2008.09.24]

Vitamin C Might Help Lower Hypertension
Source: MedicineNet High Blood Pressure Specialty [2008.09.22]

Using Honeybee Venom Toxin To Develop A New Tool For Studying Hypertension
Source: Hypertension News From Medical News Today [2008.09.19]

Prehypertension by Age 35 Clogs Arteries
Source: MedicineNet CAT Scan Specialty [2008.07.15]

more>>

Published Studies Related to Atacand HCT (Candesartan Cilexetil / Hydrochlorothiazide)

[Investigations of the antihypertensive long-term action of candesartan cilexetil in different dosages under the influence of therapy-free intervals] [2005]

Candesartan plus hydrochlorothiazide fixed combination vs previous monotherapy plus diuretic in poorly controlled essential hypertensive patients. [2004.12]

Comparative effects of candesartan and hydrochlorothiazide on blood pressure, insulin sensitivity, and sympathetic drive in obese hypertensive individuals: results of the CROSS study. [2003.09]

Comparative effects of candesartan and enalapril on left ventricular hypertrophy in patients with essential hypertension: the candesartan assessment in the treatment of cardiac hypertrophy (CATCH) study. [2002.11]

A candesartan cilexetil/hydrochlorothiazide combination tablet provides effective blood pressure control in hypertensive patients inadequately controlled on monotherapy. [2001.05]

more>>

Clinical Trials Related to Atacand HCT (Candesartan Cilexetil / Hydrochlorothiazide)

Atacand Dose Ranging in Hypertensive Pediatric Subjects 1 Year to Less Than 6 Years of Age [Active, not recruiting]

Compliance of Patients With Essential Hypertension Treated With Candesartan or Candesartan/Hydrochlorothiazide [Completed]

Candesartan and Candesartan/ Hydrochlorothiazide in the Treatment of Patients With Hypertension and LVH [Completed]

DIabetic Retinopathy Candesartan Trials. [Active, not recruiting]

Antihypertensive Efficacy and Safety of Candesartan/HCT 32/12.5 and 32/25 mg in Comparison With Candesartan 32 mg [Completed]

more>>